BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8256988)

  • 1. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss.
    Aloia JF; Vaswani A; Yeh JK; Ross PL; Flaster E; Dilmanian FA
    Ann Intern Med; 1994 Jan; 120(2):97-103. PubMed ID: 8256988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
    Civitelli R; Pilgram TK; Dotson M; Muckerman J; Lewandowski N; Armamento-Villareal R; Yokoyama-Crothers N; Kardaris EE; Hauser J; Cohen S; Hildebolt CF
    Arch Intern Med; 2002 Jun; 162(12):1409-15. PubMed ID: 12076241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
    Greenspan SL; Resnick NM; Parker RA
    JAMA; 2003 May; 289(19):2525-33. PubMed ID: 12759324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
    Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
    Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.
    Ongphiphadhanakul B; Piaseu N; Tung SS; Chailurkit L; Rajatanavin R
    Maturitas; 2000 Feb; 34(2):179-84. PubMed ID: 10714913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass.
    Aloia JF; Vaswani A; Russo L; Sheehan M; Flaster E
    Am J Obstet Gynecol; 1995 Mar; 172(3):896-900. PubMed ID: 7892882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.
    Recker RR; Davies KM; Dowd RM; Heaney RP
    Ann Intern Med; 1999 Jun; 130(11):897-904. PubMed ID: 10375338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
    Dawson-Hughes B; Dallal GE; Krall EA; Sadowski L; Sahyoun N; Tannenbaum S
    N Engl J Med; 1990 Sep; 323(13):878-83. PubMed ID: 2203964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Genazzani AR
    Maturitas; 2003 Jul; 45(3):175-83. PubMed ID: 12818462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
    Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
    Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1-y walking program and increased dietary calcium in postmenopausal women: effects on bone.
    Nelson ME; Fisher EC; Dilmanian FA; Dallal GE; Evans WJ
    Am J Clin Nutr; 1991 May; 53(5):1304-11. PubMed ID: 2021138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrone sulfate on postmenopausal bone loss.
    Genant HK; Baylink DJ; Gallagher JC; Harris ST; Steiger P; Herber M
    Obstet Gynecol; 1990 Oct; 76(4):579-84. PubMed ID: 2170884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
    Greenspan SL; Emkey RD; Bone HG; Weiss SR; Bell NH; Downs RW; McKeever C; Miller SS; Davidson M; Bolognese MA; Mulloy AL; Heyden N; Wu M; Kaur A; Lombardi A
    Ann Intern Med; 2002 Dec; 137(11):875-83. PubMed ID: 12458987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.
    Braam LA; Knapen MH; Geusens P; Brouns F; Hamulyák K; Gerichhausen MJ; Vermeer C
    Calcif Tissue Int; 2003 Jul; 73(1):21-6. PubMed ID: 14506950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
    Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
    Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.